Platelet-Rich Plasma. Clinics in sports medicine Le, A. D., Enweze, L., DeBaun, M. R., Dragoo, J. L. 2019; 38 (1): 17–44

Abstract

Platelet-rich plasma (PRP) is a promising treatment for musculoskeletal maladies and clinical data to date have shown that PRP is safe. However, evidence of its efficacy has been mixed and highly variable depending on the specific indication. Additional future high-quality large clinical trials will be critical in shaping our perspective of this treatment option. The heterogeneity of PRP preparations, both presently and historically, leads sweeping recommendations about its utility impossible to make. This heterogeneity has also made interpreting existing literature more complicated.

View details for DOI 10.1016/j.csm.2018.08.001

View details for PubMedID 30466721